|
| Press Releases |
|
 |
|
| Friday, April 17, 2015 |
|
|
Cytokinetics to Announce First Quarter Results on April 30, 2015 |
| Cytokinetics, Incorporated (Nasdaq: CYTK) announced today that it is scheduled to report first quarter results on Thursday, April 30, 2015 at 4:00 PM Eastern Time. more info >> |
|
| Tuesday, April 14, 2015 |
|
|
Cytokinetics to Host R&D Day on Tuesday, May 12, 2015 |
| Cytokinetics, Incorporated (Nasdaq: CYTK) announced today that it is scheduled to host its Research and Development Day on Tuesday, May 12, 2015. more info >> |
|
| Thursday, April 9, 2015 |
|
|
Cytokinetics to Present at the 14th Annual Needham Healthcare Conference |
| Cytokinetics, Incorporated (Nasdaq: CYTK) announced today that Robert I. Blum, President and Chief Executive Officer, is scheduled to present a corporate update at the 14th Annual Needham Healthcare Conference on Wednesday, April 15, 2015 at 11:20 AM at the Westin New York Grand Central in New York, NY. more info >> |
|
| Thursday, March 26, 2015 |
|
|
Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis |
| Cytokinetics, Incorporated (Nasdaq: CYTK) announced the publication of a manuscript relating to its fast skeletal muscle troponin activator tirasemtiv in the journal Neurotherapeutics. more info >> |
|
| Friday, March 13, 2015 |
|
|
Cytokinetics Announces Completion of Enrollment in COSMIC-HF |
| Cytokinetics, Incorporated (Nasdaq: CYTK) announced today that COSMIC-HF (Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure) has completed enrollment of the approximately 450 patients planned in the expansion phase of the clinical trial. more info >> |
|
| Friday, February 27, 2015 |
|
|
Cytokinetics Announces Publication of Preclinical Data Relating to CK-2127107 and Exercise Tolerance in Rodent Model of Heart Failure |
| Cytokinetics, Incorporated (Nasdaq: CYTK) announced the publication of a manuscript relating to its fast skeletal muscle troponin activator CK-2127107 in The Journal of Pharmacology and Experimental Therapeutics. more info >> |
|
| Wednesday, February 25, 2015 |
|
|
Cytokinetics to Present at Healthcare Conferences in March |
| Cytokinetics, Incorporated (Nasdaq: CYTK) announced today that Robert I. Blum, President and Chief Executive Officer, is scheduled to present a corporate update at the following healthcare conferences. more info >> |
|
| Friday, February 13, 2015 |
|
|
Cytokinetics, Incorporated Reports Fourth Quarter 2014 Financial Results |
| Cytokinetics, Incorporated (Nasdaq: CYTK) reported total research and development revenues for the fourth quarter of 2014 were $21.8 million, compared to $24.3 million during the same period in 2013. more info >> |
|
| Tuesday, December 23, 2014 |
|
|
Cytokinetics and Astellas Announce Expansion of Collaboration for Development of CK-2127107 in Spinal Muscular Atrophy and Other Neuromuscular Indications |
| Cytokinetics, Incorporated (NASDAQ:CYTK) and Astellas Pharma Inc. (Tokyo Stock Exchange: 4503, "Astellas") announced today an amendment to their collaboration agreement focused on the research, development and commercialization of skeletal muscle activators. more info >> |
|
| Saturday, December 6, 2014 |
|
|
Cytokinetics Announces Presentations Relating to Tirasemtiv and Effects on Respiratory Muscle Function at International Symposium on ALS/MND |
| Cytokinetics (Nasdaq: CYTK) announced today that an oral presentation and four poster presentations relating to tirasemtiv were presented at the 25th International Symposium on ALS/MND held at the Square Brussels Meeting Centre in Brussels, Belgium. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
CTF Life Collaborates with the HKMC to Refer the Policy Reverse Mortgage Programme and the Reverse Mortgage Programme
Apr 1, 2026 16:20 HKT/SGT
|
|
|
周大福人壽與香港按揭證券有限公司合作
Apr 1, 2026 16:02 HKT/SGT
|
|
|
Yuanda China's 2025 Operating Revenue Surged 27% to RMB 2.8 Billion, with a Net Profit of RMB 0.35 Billion, turning losses into gains
Apr 1, 2026 15:00 HKT/SGT
|
|
|
遠大中國2025年營收大增27%至28億元 淨利潤3.5億元扭虧為盈
Apr 1, 2026 13:10 HKT/SGT
|
|
|
远大中国2025年营收大增27%至28亿元 净利润3.5亿元扭亏为盈
Apr 1, 2026 13:04 HKT/SGT
|
|
|
芯智控股2025年淨利潤大增60.8%至1.61億港元 AI戰略驅動業績創新高
Apr 1, 2026 12:56 HKT/SGT
|
|
|
芯智控股2025年净利润大增60.8%至1.61亿港元 AI战略驱动业绩创新高
Apr 1, 2026 12:46 HKT/SGT
|
|
|
純利躍升超26倍！品創控股（8066.HK）2025年AI + 私域雙輪開啟增長新週期
Apr 1, 2026 12:37 HKT/SGT
|
|
|
MHI President Eisaku Ito Offers Words of Encouragement to New Employees at the Company's 2026 Welcoming Ceremony
Apr 1, 2026 13:35 JST
|
|
|
纯利跃升超26倍！品创控股（8066.HK）2025年AI + 私域双轮开启增长新周期
Apr 1, 2026 12:28 HKT/SGT
|
|
|
MHI Completes the Transfer Procedures for its Domestic Onshore Wind Power Business
Apr 1, 2026 13:26 JST
|
|
|
中國再保舉行2025年度業績發佈會
Apr 1, 2026 11:36 HKT/SGT
|
|
|
聯想控股2025年純利飆升近7倍 科創佈局步入效能釋放期
Apr 1, 2026 11:26 HKT/SGT
|
|
|
联想控股2025年纯利飙升近7倍 科创布局步入效能释放期
Apr 1, 2026 11:19 HKT/SGT
|
|
|
EDA集團公佈2025年全年業績
Apr 1, 2026 10:59 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
